Case Study

Optimized Cell Culture: For Bench And Beyond Case Study

Optimized Cell Culture: For Bench And Beyond

An ongoing demand for novel biopharmaceuticals, the increasing complexity of the production of biologics and a need for larger production capacity are all factors that have applied pressure to the cell culture process and its associated technologies. Cell culturing and its resources have evolved and scientists now work across numerous transformation established cell lines, primary cells and uniquely demanding cell types (e.g. stem cells) which is creating new challenges for bench and commercial scale processes. As such, the application of validated cell culture systems is essential for the safe, efficient production of monoclonal antibodies, therapeutic proteins, drugs and vaccines.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online